TABITHA MUCHLER: Open Payments
NPI 1235383647 · BROOKSVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,137 in 93 payments from 13 companies in 2025. Trend: 2023 $1,359 · 2024 $2,841 · 2025 $2,137
Food & beverage: $2,137
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $553 |
| PFIZER INC. | 16 | $241 |
| Janssen Biotech, Inc. | 10 | $225 |
| Madrigal Pharmaceuticals | 3 | $211 |
| Gilead Sciences, Inc. | 3 | $172 |
| Aimmune Therapeutics, Inc. | 11 | $169 |
| Phathom Pharmaceuticals, Inc. | 6 | $151 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $143 |
| Ardelyx, Inc. | 4 | $98 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
Products named: RINVOQ, TREMFYA, REZDIFFRA, ZENPEP, VOQUEZNA, XIFAXAN, XELJANZ, Livdelzi.
Industry payments across FL — which companies pay providers there.
